Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
about
Interleukin-1 receptor antagonist for treating periodontitisInterleukin-1 receptor antagonist for treating periodontitisAnakinra for rheumatoid arthritisLong-Term Arthralgia after Mayaro Virus Infection Correlates with Sustained Pro-inflammatory Cytokine ResponseExpression of cytokine mRNA and protein in joints and lymphoid organs during the course of rat antigen-induced arthritisActeoside suppresses RANKL-mediated osteoclastogenesis by inhibiting c-Fos induction and NF-κB pathway and attenuating ROS productionRANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapiesIL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone?Myeloid-derived suppressor cells contribute to bone erosion in collagen-induced arthritis by differentiating to osteoclasts.Synoviocyte-derived angiopoietin-like protein 2 contributes to synovial chronic inflammation in rheumatoid arthritisBone damage in rheumatoid arthritis: mechanistic insights and approaches to preventionOsteoarthritis-like damage of cartilage in the temporomandibular joints in mice with autoimmune inflammatory arthritisEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).Hydrogen sulphide decreases IL-1β-induced activation of fibroblast-like synoviocytes from patients with osteoarthritis.Cytokine-based immunointervention in the treatment of autoimmune diseases.Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectivesClinical pharmacology of old age syndromesAn expanding role for interleukin-1 blockade from gout to cancer.Carbon monoxide negatively regulates NLRP3 inflammasome activation in macrophages.Therapeutic potential of targeting IL-1 and IL-18 in inflammation.Molecular targets in immune-mediated diseases: focus on rheumatoid arthritis.Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.In Vivo Assessment of Phage and Linezolid Based Implant Coatings for Treatment of Methicillin Resistant S. aureus (MRSA) Mediated Orthopaedic Device Related Infections.Microfracture for treatment of knee cartilage defects in children and adolescentsModulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for BisphosphonatesRheumatic diseases: the effects of inflammation on bone.IL-1β reactivity and the development of severe fatigue after military deployment: a longitudinal study.Interleukin 1 receptor dependence of serum transferred arthritis can be circumvented by toll-like receptor 4 signalingModulation of Apoptosis and Differentiation by the Treatment of Sulfasalazine in Rabbit Articular Chondrocytes.Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.Use of autologous conditioned serum (Orthokine) for the treatment of the degenerative osteoarthritis of the temporomandibular joint. Review of the literatureTrolox prevents osteoclastogenesis by suppressing RANKL expression and signaling.α-Tocopheryl Succinate Inhibits Osteoclast Formation by Suppressing Receptor Activator of Nuclear Factor-kappaB Ligand (RANKL) Expression and Bone Resorption.The Basic Science of Bone Marrow Aspirate Concentrate in Chondral Injuries.Strontium ranelate in fracture healing and joint pain improvement in a rheumatoid arthritis patientTreating inflammation by blocking interleukin-1 in humans.Blocking interleukin-1β in acute and chronic autoinflammatory diseases.Mechanisms of the joint-protective effects of p38 MAPK inhibitors in rodent arthritis.Specific therapy to regulate inflammation in rheumatoid arthritis: molecular aspects.Gene Therapy for Cartilage Repair.
P2860
Q24199001-A8F1D481-B93D-4002-969B-65B97C127C76Q24240691-5A09EC66-DC02-4AFD-9951-F2708BED2517Q24241707-967DF7DC-7578-4DC4-A822-E0C52B8DF397Q24701739-32C16FC9-DF1A-45AB-88AC-2F2AA22BC6EEQ24816530-A005BC6B-FD5D-4E9D-B059-ED3D21B201C8Q28535889-8FB82EC7-1281-4786-B7DD-2C9BFCA8FC71Q28570898-781EC232-85DE-4D46-8FE7-75371666E9CEQ30251741-730B6B8C-ACB7-4632-89D7-BFF5AE0A8BDEQ30278787-D11FC37E-B527-4763-9A6A-5737DE737F48Q33816362-30EB2E25-31AC-4347-8B0F-BA0383BEFA06Q34001621-519D8198-DEE4-472B-BCD7-9DD920037602Q34728844-EF003F3E-C3FB-4CD2-A554-6EF6DDB056A9Q34768442-B3EBC3A2-DBD2-435B-9ADE-EDF2CD1BA862Q34885481-A1995ECE-C588-4972-AC72-7012A09DA6E7Q35109131-A49DC012-C4F5-41AC-89A5-EFE7475F9126Q35133812-0F190920-A0D3-4742-A8FB-04C76C64DA01Q35200049-407D6AA3-E390-4088-AF32-59754103956CQ35219001-2BF1CCD9-8E76-4AF6-9AA5-28922E27BC52Q35622507-802CDC36-82E6-4132-AEF1-434DAACC1AE4Q35790840-BE17C64A-825E-40B3-9F9A-09F4030408B7Q35911103-0DCCDCBA-21DD-4166-8C7A-61B41DB696C4Q35953302-E91D3BF5-C6E8-4E3D-99CA-71B91DDD15F6Q36059113-09C08327-09AB-493A-9BC2-BB2E95E6F126Q36092656-8C87B2D5-9734-4E09-AEBC-C7A7C6389ADDQ36101996-92B2CBC5-007E-4602-BF95-34B46B4D3598Q36324975-1C32E2F3-283F-4279-9E42-29B6ED4AC0CCQ36359892-66A18DBA-F312-4F1F-89CD-D5DE91DC0DB2Q36370656-297D8DD7-1174-4F68-9398-259F982D06A3Q36832831-33792442-1D0B-4942-8D0A-12A5701EA4B0Q36860987-CE87C56A-5239-4C0D-AB8E-63223EE4ED7EQ36891196-8E6FD2F7-3A7B-4EF6-8F14-BD123524F33CQ37185295-A6E0BAEF-0080-4191-88EB-DAC2184F4E61Q37192084-DEEEFC98-A797-4887-844C-FDC53308CAE2Q37342796-B75352B6-AB61-4375-B80B-BF73746499DDQ37567222-4DD3DA26-DFBB-46F1-9E68-AB0A280775CBQ37636664-CAAB1CA3-FF6C-499D-B7D9-4AF6B5C91845Q37821071-43517BE1-4BF7-4583-A1A5-5C371EEBDC60Q38088305-30583856-9275-42CF-954B-DEC47873C2CDQ38217595-10E6E24A-B2BA-4DD9-B315-9FAF1971ADC5Q38526206-53E2D5C4-7579-401D-85D1-EFB8EDA2F461
P2860
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@ast
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@en
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@nl
type
label
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@ast
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@en
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@nl
prefLabel
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@ast
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@en
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage.
@nl
P356
P1433
P1476
Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/41.9.972
P577
2002-09-01T00:00:00Z